Literature DB >> 35882784

Current Opinion on the Therapeutic Capacity of Taurine-Containing Halogen Derivatives in Infectious and Inflammatory Diseases.

Janusz Marcinkiewicz1, Markus Nagl2, Anthony Kyriakopoulos3, Maria Walczewska4, Magdalena Skóra5, Paulina Skalska4.   

Abstract

Taurine haloamines, N-chlorotaurine (NCT, TauCl), and N-bromotaurine (NBT, TauBr) are formed by a reaction between taurine and hypohalous acids, HOCl and HOBr, respectively. The major source of endogenous taurine haloamines is neutrophils. Both NCT and NBT share strong anti-inflammatory and microbicidal activities supported by an absence of microbial resistance. In the light of these properties, a number of clinical studies have been performed to document their effectiveness in treatment of bacterial, fungal, and viral infections. The administration of NCT and NBT has been limited to topical application, as they are decomposed upon systemic delivery. This review summarizes current knowledge concerning the therapeutic use of NCT and NBT mainly in various skin disorders such as non-healing wounds, acne vulgaris, herpes zoster, and psoriasis. Moreover, the beneficial effect of NCT inhalation in early stages of COVID-19 and other viral respiratory infections is discussed. And finally, we would like to suggest that NCT might be used to inhibit the development of the cytokine storm through its capacity to suppress the production of IL-6.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  COVID-19; Infection diseases; Inflammation; N-bromotaurine; N-chlorotaurine; Taurine bromamine; Taurine chloramine; Taurine derivatives

Mesh:

Substances:

Year:  2022        PMID: 35882784     DOI: 10.1007/978-3-030-93337-1_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   3.650


  96 in total

Review 1.  Antifungals.

Authors:  Sonia Campoy; José L Adrio
Journal:  Biochem Pharmacol       Date:  2016-11-21       Impact factor: 5.858

Review 2.  Role of taurine, its haloamines and its lncRNA TUG1 in both inflammation and cancer progression. On the road to therapeutics? (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Int J Oncol       Date:  2020-07-14       Impact factor: 5.650

3.  Influence of poly-N-acetylglucosamine in the extracellular matrix on N-chlorotaurine mediated killing of Staphylococcus epidermidis.

Authors:  Christoph G Ammann; Manfred Fille; Johann Hausdorfer; Michael Nogler; Markus Nagl; Débora C Coraça-Huber
Journal:  New Microbiol       Date:  2014-07-01       Impact factor: 2.479

4.  Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity.

Authors:  M Barua; Y Liu; M R Quinn
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

5.  Microbicidal activity of monochloramine and chloramine T compared.

Authors:  R Arnitz; M Nagl; W Gottardi
Journal:  J Hosp Infect       Date:  2009-08-31       Impact factor: 3.926

Review 6.  Azole Resistance in Aspergillus fumigatus: A Consequence of Antifungal Use in Agriculture?

Authors:  Sarah Berger; Yassine El Chazli; Ambrin F Babu; Alix T Coste
Journal:  Front Microbiol       Date:  2017-06-07       Impact factor: 5.640

7.  Bromamine T, a stable active bromine compound, prevents the LPS‑induced inflammatory response.

Authors:  Stella Baliou; Michael Sofopoulos; Maria Goulielmaki; Demetrios A Spandidos; Petros Ioannou; Anthony M Kyriakopoulos; Vassilios Zoumpourlis
Journal:  Int J Mol Med       Date:  2021-02-04       Impact factor: 4.101

8.  N-chlorotaurine, a potent weapon against multiresistant bacteria.

Authors:  C Anich; D Orth-Höller; M Lackner; M Nagl
Journal:  J Appl Microbiol       Date:  2021-02-27       Impact factor: 3.772

Review 9.  Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2.

Authors:  F Carrouel; L S Gonçalves; M P Conte; G Campus; J Fisher; L Fraticelli; E Gadea-Deschamps; L Ottolenghi; D Bourgeois
Journal:  J Dent Res       Date:  2020-10-22       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.